Cardiovascular Disease
3 competing products in clinical development for Cardiovascular Disease.
Pipeline by Phase
Phase 11
Phase 31
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lorcaserin hydrochloride + Placebo | Eisai | Approved | Completed | 43 |
| Dulaglutide + Placebo | Eli Lilly | Phase 3 | Completed | 40 |
| Evacetrapib | Eli Lilly | Phase 1 | Completed | 29 |